Renaissance Technologies’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,502,100
| Closed | -$170M | – | 3872 |
|
|
2019
Q3 | $170M | Sell |
2,502,100
-312,400
| -11% | -$21.5M | 0.14% | 145 |
|
|
2019
Q2 | $164M | Buy |
2,814,500
+435,000
| +18% | +$25.8M | 0.14% | 154 |
|
|
2019
Q1 | $167M | Buy |
2,379,500
+432,400
| +22% | +$32.1M | 0.15% | 148 |
|
|
2018
Q4 | $125M | Buy |
1,947,100
+164,000
| +9% | +$11.5M | 0.14% | 156 |
|
|
2018
Q3 | $125M | Buy |
1,783,100
+378,176
| +27% | +$22.1M | 0.13% | 167 |
|
|
2018
Q2 | $70.8M | Buy |
1,404,924
+222,324
| +19% | +$8.82M | 0.08% | 304 |
|
|
2018
Q1 | $37M | Buy |
1,182,600
+170,600
| +17% | +$5.66M | 0.04% | 572 |
|
|
2017
Q4 | $34.6M | Buy |
1,012,000
+141,300
| +16% | +$4.51M | 0.04% | 613 |
|
|
2017
Q3 | $27.9M | Buy |
870,700
+57,400
| +7% | +$1.81M | 0.03% | 697 |
|
|
2017
Q2 | $26.5M | Buy |
813,300
+80,100
| +11% | +$2.54M | 0.03% | 695 |
|
|
2017
Q1 | $23.1M | Buy |
733,200
+156,500
| +27% | +$4.63M | 0.03% | 717 |
|
|
2016
Q4 | $16.9M | Buy |
576,700
+29,100
| +5% | +$887K | 0.03% | 893 |
|
|
2016
Q3 | $15.8M | Buy |
547,600
+111,500
| +26% | +$3.11M | 0.03% | 852 |
|
|
2016
Q2 | $11.3M | Sell |
436,100
-9,921
| -2% | -$264K | 0.02% | 1067 |
|
|
2016
Q1 | $11M | Buy |
446,021
+156,421
| +54% | +$4.29M | 0.02% | 1071 |
|
|
2015
Q4 | $10.2M | Buy |
289,600
+55,800
| +24% | +$1.49M | 0.02% | 978 |
|
|
2015
Q3 | $4.95M | Sell |
233,800
-33,400
| -13% | -$861K | 0.01% | 1406 |
|
|
2015
Q2 | $7.42M | Buy |
267,200
+230,300
| +624% | +$6.5M | 0.02% | 1170 |
|
|
2015
Q1 | $1.13M | Buy |
36,900
+24,700
| +202% | +$785K | ﹤0.01% | 2246 |
|
|
2014
Q4 | $390K | Buy |
+12,200
| New | +$397K | ﹤0.01% | 2505 |
|
|
2014
Q2 | – | Sell |
-108,555
| Closed | -$2.86M | – | 3073 |
|
|
2014
Q1 | $2.86M | Buy |
108,555
+55,654
| +105% | +$1.6M | 0.01% | 1582 |
|
|
2013
Q4 | $1.55M | Buy |
52,901
+15,101
| +40% | +$479K | ﹤0.01% | 1873 |
|
|
2013
Q3 | $1.16M | Sell |
37,800
-129,200
| -77% | -$4.32M | ﹤0.01% | 1941 |
|
|
2013
Q2 | $5.3M | Buy |
+167,000
| New | +$5.49M | 0.01% | 1075 |
|
Renaissance Technologies's GHDX Position: Q4 2019 in Review
Renaissance Technologies sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 2,502,100 shares — an estimated $170M sold.
Renaissance Technologies first reported a position in GHDX in Q2 2013 and held it in 24 quarters. The position peaked at $170M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Renaissance Technologies reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Renaissance Technologies sold 2,502,100 Genomic Health, Inc. shares in Q4 2019, an estimated $170M.
- Renaissance Technologies first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 24 quarters.
- Renaissance Technologies's Genomic Health, Inc. position peaked at $170M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.